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Abstract
Background: Chronic pulmonary embolism (CPE) is a life-threatening disease easily misdiagnosed on computed
tomography. We investigated a three-dimensional convolutional neural network (CNN) algorithm for detecting
hypoperfusion in CPE from computed tomography pulmonary angiography (CTPA).
Methods: Preoperative CTPA of 25 patients with CPE and 25 without pulmonary embolism were selected. We
applied a 48%–12%–40% training-validation-testing split (12 positive and 12 negative CTPA volumes for training, 3
positives and 3 negatives for validation, 10 positives and 10 negatives for testing). The median number of axial
images per CTPA was 335 (min–max, 111–570). Expert manual segmentations were used as training and testing
targets. The CNN output was compared to a method in which a Hounsfield unit (HU) threshold was used to detect
hypoperfusion. Receiver operating characteristic area under the curve (AUC) and Matthew correlation coefficient
(MCC) were calculated with their 95% confidence interval (CI).
Results: The predicted segmentations of CNN showed AUC 0.87 (95% CI 0.82–0.91), those of HU-threshold method
0.79 (95% CI 0.74–0.84). The optimal global threshold values were CNN output probability ≥ 0.37 and ≤ -850 HU.
Using these values, MCC was 0.46 (95% CI 0.29–0.59) for CNN and 0.35 (95% CI 0.18–0.48) for HU-threshold method
(average difference in MCC in the bootstrap samples 0.11 (95% CI 0.05–0.16). A high CNN prediction probability was
a strong predictor of CPE.
Conclusions: We proposed a deep learning method for detecting hypoperfusion in CPE from CTPA. This model
may help evaluating disease extent and supporting treatment planning.
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Key points
 The study aim was to detect hypoperfusion in
chronic pulmonary embolism.
 Convolutional neural network was applied to
computed tomography pulmonary angiography
images.
 Good accuracy with moderate segmentation
correlation to manual delineations was achieved.
 The model offered an improvement compared to a
computed tomography density-based analysis.
Background
Chronic thromboembolic pulmonary hypertension
(CTEPH) is a late complication of pulmonary embolism
[1, 2]. Unresolved thrombus is seen in 15–30% of pa-
tients 9–12months after the initial pulmonary embolism
[3, 4], which may organise and progress into chronic
thromboembolic disease (CTED) [5]. Pulmonary vascu-
lopathy may occur in the nonoccluded arteries [6]. Con-
sequently, pulmonary vascular resistance and arterial
pressure increase developing CTEPH [7] with a cumula-
tive incidence of 0.1–9.1% within 2 years after a symp-
tomatic pulmonary embolism event [8]. The incidence
of CTED is estimated to be significantly higher [9]. Un-
like other forms of pulmonary hypertension (PH), CTEP
H is potentially curable surgically with pulmonary end-
arterectomy [10, 11]. If untreated, the median survival is
less than 2 years if the mean pulmonary arterial pressure
is > 30 mmHg [1, 2]. Hence, early diagnosis is cardinal
for these patients.
The screening method of choice for CTEPH is ventila-
tion/perfusion (V/Q) scan [12] while catheter-directed
pulmonary angiography is considered the reference
standard in confirming the diagnosis [13, 14]. Computed
tomography pulmonary angiography (CTPA) can also be
used to confirm the diagnosis of CTEPH [15–17] and es-
timate the severity of the pulmonary hypertension [18,
19]. Despite its low sensitivity in clot detection in the
distal and subsegmental vessels [20], CTPA is funda-
mental in the diagnostic workup of CTEPH with a cru-
cial role in assessing the feasibility of surgical treatment
[17]. CTPA is noninvasive and more widely available
than catheter-directed pulmonary angiography and has
the advantage of evaluating the parenchymal and bron-
chial signs, the collateral circulation, and competing
diagnoses [21].
In CTPA, the vascular signs for chronic pulmonary
embolism (CPE) are complete occlusion of the pulmon-
ary arteries or incomplete occlusion by nonobstructing
bands, webs, or laminated thrombi [5, 21]. A typical par-
enchymal sign for CPE is mosaic perfusion, seen as well-
demarcated regions of hypoattenuation representing hy-
poperfusion and hyperattenuating regions representing
the blood flow to the patent pulmonary vascular bed [5,
21]. These radiological signs are frequently missed in the
reports [22], and because of the disease insidious nature
and the unspecific clinical presentation [23], the diagno-
sis is often delayed, with a median of 14 months after
the initial symptoms [24]. A high index of suspicion is
necessary for the diagnosis [21].
Several techniques have been developed for computer-
aided detection and diagnosis of pulmonary embolism
[25, 26]. However, no studies have been done on artifi-
cial intelligence techniques to detect parenchymal
changes from CTPA relating to hypoperfusion in CPE.
An automatic tool detecting these perfusion defects from
CTPA images could potentially aid in diagnostics, evalu-
ating the extent of the disease, and treatment planning
of chronic pulmonary embolism. This study aimed to
train a convolutional neural network (CNN) to detect
the hypoperfused regions affected by CPE from CTPA
images and evaluate the algorithm performance in this
task.
Methods
Subjects and imaging parameters
We retrospectively reviewed reports of V/Q scans per-
formed in Helsinki University hospital between January
2017 and December 2019. Based on the reports, 30 pa-
tients with findings suggestive of CPE in the V/Q scan
were selected for the study. Also, 31 patients with no
signs of pulmonary embolism in the V/Q scan were
selected.
The inclusion criteria for the positive cases were a
positive V/Q scan for CPE and a CTPA with signs of
CPE performed in our hospital district within 3 months
before or after the positive V/Q scan before treatment
without signs of acute pulmonary embolism. Cases with
no possibility to delineate areas of hypoperfusion at
CTPA were excluded from the study. The negative pa-
tients’ inclusion criteria were a negative V/Q scan for
acute or chronic pulmonary embolism and a negative
CTPA for acute or chronic pulmonary embolism per-
formed within three months of the negative V/Q scan.
In both groups, CTPA studies, in which the radiological
signs of a parenchymal disease unrelated to CPE (e.g.,
hyperattenuation caused by talcosis) extended over two
thirds of the lung volume, were excluded. Artefacts
caused by foreign material that covered more than one
third of the lung volume in the CTPA was a criterion for
exclusion in both groups.
Five patients with positive findings were excluded from
the study for the lack of presurgical CTPA in the picture
archive, a lack of visible parenchymal hypoattenuation in
the CTPA, lungs completely affected by CPE on the V/Q
scan without demarcating difference of attenuation at
CTPA, no CTED or CTEPH diagnosed clinically, and
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inclusion of a massive acute or chronic thromboembol-
ism. Six patients with CPE-negative findings were ex-
cluded based on too large slice thickness on CTPA in
our picture archive, parenchymal lesions covering over
two thirds of the lung volume related to another disease
(talcosis), acute pulmonary embolism, a suspicion of
CPE at CTPA (two patients), and significant artefacts on
CTPA related to prior surgery. After the exclusion, 25
positive (group A) and 25 negative (group B) cases were
included in the study. Patient demographics are shown
in Table 1.
In group A, 18 patients had a clinical diagnosis of
CTEPH, clinically defined as the mean pulmonary arter-
ial pressure > 25mmHg at rest, pulmonary capillary
wedge pressure < 15 mmHg documented with a right
heart catheterisation, persisting mismatched perfusion
defect in V/Q scan with specific diagnostic signs for
CTEPH on CTPA or conventional pulmonary angiog-
raphy [27]. Seven patients had CTED, defined with the
same criteria as mentioned above, excluding pulmonary
hypertension [28]. Seventeen patients with CTEPH had
pulmonary hypertension confirmed with a right heart
catheterisation. One CTEPH patient had only an echo-
cardiogram done for the diagnosis. A normal pulmonary
arterial pressure was confirmed with a right heart cath-
eterisation for one of the patients with CTED. The rest
did not warrant a right heart catheterisation.
The CTPA studies were performed before treatment
on various scanners in multiple hospitals within the
Hospital District of Helsinki and Uusimaa. The protocol
was defined by the joint municipal authority for specia-
lised healthcare. Different tube voltages were used de-
pending on the scanner and the size of the patient (see
Table 2 for details). All data were anonymised and
stored on a server running the Extensible Neuroimaging
Archive Toolkit version 1.1.6 [29].
Preprocessing
A radiologist with over 5 years of experience manually
segmented the hypoperfused regions on the CTPA im-
ages for the 25 patients in group A, using V/Q scan im-
ages as a reference for segmentation. To appreciate the
minor differences in the parenchymal attenuation, grey-
level mapping with a window width ranging from 200 to
900 and a window level ranging from -1,100 to -800 was
used. Only the regions of hypoperfusion visible in the
CTPA were segmented. Regions where hypoattenuation
was suspectedly caused by lung disease other than CPE
were not segmented. Areas with relevant artefacts relat-
ing to, e.g., motion or beam hardening, were left unseg-
mented. Regions smaller than 5 mL were left
unsegmented. Hyperattenuating lesions relating to the
CPE were included in the segmentation, e.g., lung infarc-
tions and atelectasis in the diseased area if seen in the
hypoperfused region. Segmentation was done on the
axial images using the image processing and visualisation
platform 3D Slicer [30].
Due to a large number of axial images, with a me-
dian of 335 (min–max, 111–570) per CTPA, we used
a tool based on morphological contour interpolation
for assistance in segmentation [31], which allowed
any number of slices to be skipped between slices
segmented manually. This tool interpolates the manu-
ally segmented slices by detecting and aligning over-
lapping shapes in the adjacent segmented slices and
generating a transition sequence of one-pixel dilata-
tion between the overlapping shapes, and a median of
this sequence is taken as a result to fill the skipped
slices [31, 32]. The radiologist segmented the hypo-
perfused regions to every 3–10 axial images by hand,
and the complete segmentation was created by the
interpolation tool. Contours of the interpolation were
evaluated and approved by the radiologist before
committing to the segmentation. If the radiologist dis-
agreed with the interpolation, the contours of the in-
terpolated segmentation were modified and corrected
manually. In group A, segmentation was done in this
manner to every axial CTPA image for the CNN
training and analysis. In group B, there was no man-
ual segmentation done for hypoperfusion. Addition-
ally, in both groups, the lungs were segmented as a
whole, and the CTPA image data outside of the lungs
was excluded from the analysis.
We applied a 48%–12%–40% training-validation-test
split, i.e., 12 CTEPH positive and 12 negative CTPA vol-
umes for training, 3 positives and 3 negatives for valid-
ation, 10 positives, and 10 negatives for testing. We split
the data temporally: all the training and validation data
had been imaged before all the test data. The hospital
ethics committee approved the study. Informed consent
was waived because of the retrospective design and an-
onymous clinical data used for the analysis.
Table 1 Patient demographics
Median age (years, min–max) Males Females CTEPH patients CTED patients
Group A 67 (21–82) 8 17 18 7
Group B 67 (33–88) 11 14 0 0
All 67 (21–88) 19 31 18 7
CTEPH Chronic thromboembolic hypertension, CTED Chronic thromboembolic disease
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Neural network training
We trained a 12 layers deep U-net-type [33] CNN with
three-dimensional convolutional layers (3 × 3 × 3 kernel
size; valid padding; 16, 32, or 64 filters each), three max-
pooling/upsampling steps with skip connections, and a
single output neuron with sigmoid activation (see details
in Fig. 1). Exponential linear units were used as activa-
tions in the hidden layers. The CNN was implemented
using Keras in Tensorflow framework version 2.0 [34].
The compute tomography (CT) angiography volumes
were resampled to uniform 1 × 1 × 1mm3 and normal-
ised by linearly shifting and scaling the -900…-600 HU
range into -1…1 range. The training data were divided
into 32 × 32 × 32 voxel patches, and the patches com-
pletely outside the lung region were rejected. These sam-
ples with borders extended by 30 voxels on each side
(due to a valid padding scheme in all the convolutional
layers) were fed into the network with batch size 16.
During training, Adam optimiser [35] with 2 × 10−4
learning rate and Dice loss [36] against manual labels
were used. The final model was achieved after 21
epochs, at which point the validation accuracy stopped
improving. Also, no further improvement on validation
data was achieved by lowering the learning rate after the
21st epoch.
Performance and statistical testing
We compared the CNN model to a method which used
a simple cutoff Hounsfield units (HU) threshold: voxels
inside the lungs with a HU value below a specific thresh-
old value were labelled as hypoattenuation. Hereafter,
we will refer to this global threshold approach as the
“naïve HU-threshold method”, in contrast to an active
expert-selected threshold for each patient or region. We
calculated the voxel segmentation receiver operating
characteristic curves for these two methods and com-
pared the area under curve (AUC) values produced by
the CNN model and the naïve HU-threshold method.
Table 2 Number of patients imaged with each computed tomography scanner and tube voltage
Tube voltage
Scanner model (manufacturer) 80 kV 100 kV 120 kV 140 kV Total
Somatom Definition AS (Siemens Healthineers) 0 2 1 0 3
Discovery HD (General Electric Healthcare) 0 4 0 0 4
Somatom Definition Edge (Siemens Healthineers) 1 6 1 2 10
Somatom Definition Flash (Siemens Healthineers) 0 9 2 0 11
Lightspeed VCT (General Electric Healthcare) 0 9 1 0 10
Aquilon Prime (Toshiba) 0 1 0 0 1
Revolution EVO (General Electric Healthcare) 0 2 2 0 4
Revolution HD (General Electric Healthcare) 1 5 0 1 7
Total 2 38 7 3 50
Patients were imaged with one of the eight scanner models depending on the referring hospital. Tube voltages ranged from 80 kV to 140 kV
Fig. 1 The convolutional neural network architecture was based on U-net with three max-pooling steps in the downsampling pathway and linear
upsampling in the resolution recovery path. Convolutional layers (C) were followed by batch or group normalisation and exponential linear unit
(ELU) activations. Skip connections with cropping were used between the matching resolution levels (dashed arrows). C Convolutional layer, BN
Batch normalisation, ELU Exponential linear unit, GN Group normalisation
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Due to inherent class imbalance in the dataset (21% of
lung voxels in the total dataset were labelled as hypoper-
fused), we chose the Matthews correlation coefficient
(MCC) [37] as the segmentation performance metric.
Secondly, in contrast to the more commonly used F1
metric, which emphasises the positive class, MCC re-
mains agnostic of which of the binary classes is selected
“positive”. Therefore, we avoid imposing hypoattenuat-
ing areas to be more important than the remaining tis-
sues in the segmentation performance evaluation.
Confidence intervals (CIs) for the reported performance
metrics were calculated using a bootstrap method by re-
sampling with replacement with 105 repeats and 95%
significance level. The optimal threshold for visual in-
spections was chosen by maximising the test set bal-
anced accuracy. We evaluated the test cases visually to
assess the clinical relevance of the false positive and
negative segmentations. We further investigated if the
CNN probability or the mean HU could indicate the
presence of the CPE.
Results
Segmentation performance
An example of manual, naïve HU-threshold and CNN
segmentations is shown in Fig. 2. Time for manual seg-
mentation was approximately 5 h per case.
Using the naïve HU-threshold method over all the test
samples, the ROC AUC was 0.79 (95% CI 0.74–0.84);
using the CNN model the ROC AUC was 0.87 (0.82–
0.91) (see Fig. 3). The optimal global threshold value was
≤ -850 HU for the threshold method and CNN output
probability ≥ 0.37. We used these values in the following
MCC and visual assessments. MCCs were 0.35 (95% CI
0.18–0.48) and 0.46 (95% CI 0.29–0.59), for the naïve
HU-threshold method and the CNN model, respectively.
The average difference in the MCCs between the two
methods in the bootstrap samples was 0.11 (95% CI
0.05–0.16; positive value meaning CNN performed bet-
ter). Because the 95% CI excluded zero, we conclude in
favour of a statistically significant improvement achieved
by using the CNN model.
Visual assessment
Complementary to voxel-wise performance evaluation,
we reviewed each test set CTPA by visually assessing in-
dividual regions segmented by the CNN model and the
naïve HU-threshold method (Fig. 4). Regions overlap-
ping the manually segmented areas were defined as true
positives. Regions not overlapping with the manually
segmented areas were defined as false positives. Manu-
ally segmented regions not overlapping with the segmen-
tation done by the prediction algorithm were defined as
false negatives. If more than one part segmented by the
prediction algorithm overlapped a same manually
segmented region, they were all defined together as one
true positive. We ignored prediction labels outside the
lung parenchyma.
In the CNN output, there were 63 independent false
positive labels in group A and 111 false positive labels in
group B, respectively. Beam hardening artefacts from the
larger organs, including the heart, the hilum of the lung,
the aorta, and the diaphragm, were seen in 17% of the
false positives. In 16%, there were beam hardening arte-
facts relating to the contrast material bolus in either su-
perior vena cava, subclavian, or brachiocephalic veins.
Thirty-three per cent of the false positives were adjacent
to smaller blood vessels and 15% were minor subpleural
regions most likely related to beam hardening (Fig. 5).
Twelve areas of varying sizes were labelled positive by
the CNN, which were incorrectly labelled negative in the
preprocessing. Nine per cent of the false positives
remained unspecific by nature. In one case, there was air
trapping relating to a mucus plug in a bronchus. One
patient in group B had gone through left upper lobe
pneumonectomy in the past, and the majority of the
remaining lung volume was detected as false positive by
the CNN algorithm and HU-threshold method (false
positive outlier, Fig. 6b; Fig. 7).
Of the 137 manually segmented lesions, 133 were cor-
rectly labelled positive by the CNN. There were both
overestimation and underestimation of these lesions.
The overestimation of 8 true positive labels was related
to hypoattenuation caused by beam hardening artefacts.
Otherwise, the cause of the overestimation and under-
estimation remained unspecific.
In the naïve HU threshold algorithm, each voxel below
the certain threshold was labelled as positive. With the
optimal HU-threshold of < -850, the result consisted of
numerous voxel clouds of different sizes, including sin-
gle voxels, because no voxel clustering was used. As this
method labelled a myriad of regions positive, ranging
from one voxel size to larger areas, it was not reasonable
to count them. Hence, we present the visual assessment
of the naïve HU-threshold method descriptively.
The naïve HU threshold algorithm responded to gen-
eral noise in the lung parenchyma consisting of both
morphologic variegation and imaging noise, which can
be seen in the healthy and disease-associated lung paren-
chyma. Hypoattenuating voxels caused by artefacts were
also marked as false positives. Each manually segmented
hypoperfusion area contained at least one voxel labelled
as true positive. As shown in Fig. 6, both the mean over
the lung tissue with < -850 HU and the average CNN
prediction probability, i.e., network’s confidence in the
voxel segmentation, indicate the presence of CPE. Using
the CNN and value 0.55 (dashed line in Fig. 6b), all but
one test case was correctly categorised. The network in-
ference time of the CNN model for a single CTPA in
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the test set was between 17 and 32 s using an NVIDIA
Quadro M6000 24GB graphics card.
Discussion
As far as we know, this is the first study to evaluate the
feasibility of three-dimensional CNN in the detection of
lung hypoperfusion from CTPA images in CPE. Our
CNN algorithm showed an encouraging performance in
detecting these lesions on a separate testing set. Since
there are no previous studies to compare our results to,
we compared the CNN algorithm to a method based on
a simple HU cutoff threshold. Using even the HU
threshold segmentation could help visual evaluation, but
according to our results, the CNN algorithm could offer
a significant improvement with a 0.87 ROC-AUC and
0.46 MCC compared to the 0.79 and 0.35 for the naïve
HU-threshold method, respectively.
The average CNN prediction probability indicates the
presence of CPE, and all but one of the CPE and control
cases in the test set were correctly categorised using a
probability value 0.55. Therefore, we propose that in
addition to the lesion segmentation, the disease overall
presence could be inferred using a CNN-based
approach.
The CNN algorithm recognised most (97%) of the
manually segmented lesions. Majority (82%) of the false
positive CNN labels were small and related to beam
hardening artefacts from dense organs, which seemed to
be the most challenging for the CNN to differentiate
from true positive lesions. However, one patient had
Fig. 2 An example of computed tomography angiography volume (a) segmentations with good agreement to manual delineations (blue
outline): HU threshold (≤ -850)-derived segmentation is shown in green (b), while the prediction of convolutional neural network is shown as
colourmap (≥ 0.37 probability cutoff) (c). HU Hounsfield units
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extensive false positive labels covering most of the lung
volume. This patient had undergone left upper lobe
pneumonectomy and mean HU of the lung parenchyma
was one of the lowest in the study group. After lobec-
tomy, the remaining lung has a relative increase of air
and a decrease of the lung parenchyma in the thorax
seen as hyperlucency on a CT image [38]. This is likely
the reason for the hyperlucency in this patient’s lung
and the CNN false positive labelling.
There was both overestimation and underestimation
in the sizes of the hypoperfused lesions. The overesti-
mation was partly related to the beam hardening arte-
facts mentioned earlier, but in most cases, the
overestimation and underestimation remained unspe-
cific. Since accurate delineation of the hypoattenuating
regions in the CTPA was challenging, we had to com-
promise the manual segmentation in cases where the
borders between affected and unaffected areas were gra-
dient. This might partially explain the overestimation
and underestimation of the lesion sizes in the labels out-
put by the CNN algorithm.
CNNs have been previously applied in pulmonary em-
bolism detection based on labelling the occluding clots
seen in CTPA as filling defects of intravascular contrast
material in pulmonary arteries [39–42]. These studies
have focused mainly on acute pulmonary embolism. We
took a different approach, and instead of the actual vas-
cular defects, we focused on the hypoattenuation in the
lung parenchyma relating to the hypoperfusion caused
by chronic pulmonary embolism. Öman et al. (2019)
have successfully implemented this type of approach to
detect acute stroke lesions from CT angiography images
with a CNN based algorithm [43]. However, since the
lungs are composed largely of air, the differences in par-
enchymal enhancement are subtler between the hypo-
and hyperperfused regions at CTPA than at CT angiog-
raphy of the brain. Another significant difference in the
setting is that a single thrombus usually causes the is-
chemic stroke, whereas chronic pulmonary embolism af-
fects many branches of the pulmonary vasculature by
various degrees of obstruction. Unlike the brain, the at-
tenuation of the lung is sensitive to regional
Fig 3 Receiver operating characteristic curves when applying the convolutional neural network (CNN) model or using a global naïve Hounsfield
unit threshold method. The areas under the curves were 0.87 and 0.79, respectively. HU Hounsfield units
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abnormalities of perfusion or aeration, which can be
seen as heterogeneous lung attenuation on CT [44].
In patients with CPE, the areas of low attenuation on
CTPA represent areas of hypoperfusion [45], which is
due to both the obstructing vascular impairment caused
by chronic thrombus and the vasculopathy in the regions
clear of the thrombus [6]. The low attenuation may also
be due to air trapping in CTEPH patients relating to ab-
normalities in the affected regions' small airways [46].
Our study had only CTPA studies without expiration
images, so we could not definitely differentiate the hypo-
perfusion and air trapping. However, regardless of the
cause, hypoattenuation is associated with the regions af-
fected by CTE, and, i.e., Bartalena et al. [47] showed that
the hypoattenuating regions seen in CTPA correlated
well with hypoperfusion seen in perfusion scintigraphy
of patients with pulmonary hypertension including
CTEPH.
Absence of mosaic perfusion is not exclusive for CPE
as in some studies up to 26–45% of patients with CTEP
H did not present mosaic perfusion at CTPA [12, 48].
The mosaic perfusion is also not specific for CPE, and
various diseases mimic this pattern [49]. Hence, this type
of CNN algorithm would not be a comprehensive tool
for the diagnosis or exclusion of CPE, but it may help as-
sess the extent of the disease and treatment planning.
With a processing time well below 1 min, the CNN
model could be implemented as a low-latency clinical
application in the picture archiving and communication
system by overlaying the prediction on top of the images
or by reporting the volume(s) of the hypoperfused re-
gions. This type of application might also assist the
Fig. 4 An example case (a) of an overall low attenuation where a predefined HU-threshold (≤ -850 HU shown in green in b performs
suboptimally compared to the convolutional neural network model (c) when compared to manual segmentation (blue outlines). HU
Hounsfield units
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Fig. 5 Common false negative convolutional neural network predictions were related to beam hardening artefacts seen adjacent to dense
contrast material in the subclavian vein (a), around vessel (b) in subpleural sites (b), and adjacent to larger organs like the heart and the hilum (c)
Fig. 6 CPE cases (test set cases of group A) are indicated with crosses and the controls (test set cases of group B) with circles. CPE Chronic
pulmonary embolism, HU Hounsfield units
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radiologist in diagnosing CPE, which is often misdiag-
nosed and difficult to detect, especially if combined with
an algorithm assessing the vascular defects. A more ex-
tensive database is needed to conclude the feasibility of
CNN algorithms in a clinical setting and with automatic
methods of detecting the vascular defects.
A limitation of our study was that the labels were
manually segmented by a single radiologist and con-
tained an unknown interobserver variability and individ-
ual bias level. Contributing to this label noise was the
lack of expiration CT scans, and definite differentiation
between hypoperfusion and air trapping was not pos-
sible. Additionally, borders between the regions with dif-
fering perfusion were gradient in many cases, and exact
demarcation was not always univocal during the pre-
processing, which might explain some of the overesti-
mation and underestimation of the lesions by the CNN
algorithm.
The patients in the study had different parenchymal
changes relating to other diseases (e.g., scars, atelec-
tasis, pleural fluid, emphysema, inflammatory lesions),
and all the patients who had these types of findings
extended to over two thirds of the lung volume were
excluded from the study. Although this exclusion
criterion presents an unknown amount of bias in the
sample profile, we found it necessary. Otherwise, the
manual segmentation could not have been done ob-
jectively, leaving the segmentations too imprecise. To
avoid inaccurate labelling, the smallest regions of hy-
poperfusion and regions with undefined borders relat-
ing to noise and artefacts were left manually
unlabelled. The segmentation was done correspond-
ingly for the whole group A (divided for the training,
validation and the test sets). This had an unknown ef-
fect on the results as the CNN labelled some of these
small regions correctly as hypoperfusion. Still, they
presented as false positives since the manual segmen-
tation was considered the ground truth. New practical
methods for improved manual segmentation and la-
belling the parenchymal lesions in the lungs need to
be explored. One such tool is the morphological con-
tour interpolation introduced by Zukić et al. [31],
which implements a morphology-based interslice
interpolation proposed by Albu et al. [32]. In our
study, this tool turned out invaluable for the manual
segmentation since the lesions were large in number
and volume with irregular shapes and borders, and
not always well demarcated in every CT slice.
Fig. 7 One patient with previous upper lobe left pneumonectomy, and the remaining lung parenchyma was low in HU, resulting in large false
positive predictions by the convolutional neural network. HU Hounsfield units
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Finally, we acknowledge as a study limitation the small
sample size, for which only a modest anatomical and
pathological variation were available during training.
Also, the small number of validation cases may have led
to a suboptimal stopping point and model selection.
Nevertheless, to address the resulting problem of un-
known generalizability, the data portion dedicated to
testing was kept relatively high in the study design.
Likely, a big data approach (e.g., training with additional,
more readily available, non-CPE cases) would be benefi-
cial, especially in decreasing the extent and frequency of
false-positive regions.
In conclusion, this study demonstrated the feasibility
of a deep learning algorithm for the detection of hypo-
perfusion in CPE from CTPA with a good performance.
These encouraging findings suggest that CNNs could be
used as an automated method for assisting the clinician
and radiologist in diagnosis and treatment planning for
patients with CPE.
Abbreviations
AUC: Area under curve; CI: Confidence interval; CPE: Chronic pulmonary
embolism; CT: Computed tomography; CTED: Chronic thromboembolic
disease; CTEPH: Chronic thromboembolic pulmonary hypertension; CTPA: CT
pulmonary angiography; MCC: Matthews correlation coefficient; V/
Q: Ventilation/perfusion
Acknowledgements
Eero Salli, PhD (Tec.) and Ulla Wilppu, M.Sc. (Tec.) are acknowledged for their
technical assistance and stimulated discussions during the project.
Authors’ contributions
All the authors participated in planning the study. TV did the patient
selection, clinical analysis, review, and manual segmentation of the patient
cases. TM designed the pre-processing and analysis phases. The neural net-
work workflow was implemented by TM. MK and SS gave valuable medical
and technical insight throughout the project. TM and TV prepared the body
of the manuscript. All the authors have improved and approved the
manuscript.
Funding
This study received research and development funding from
Helsinki University Hospital (SS: TYH2019253, MK: Y780020122 and TV:
Y780019034).
Availability of data and materials
The trained deep learning models are available on reasonable request sent
to the corresponding author.
Declarations
Ethics approval and consent to participate
Ethical committee approved this retrospective study, and patients’ informed
consent was waived.
Consent for publication
Not applicable.
Competing interests
The authors have no conflicts of interest to declare.
Author details
1HUS Medical Imaging Center, Radiology, University of Helsinki and Helsinki
University Hospital, P.O. Box 340 (Haartmaninkatu 4), FI-00290 Helsinki,
Finland. 2Department of Physics, University of Helsinki, P.O. Box 64, FI-00014
Helsinki, Finland.
Received: 15 February 2021 Accepted: 26 July 2021
References
1. Lewczuk J, Piszko P, Jagas J, et al (2001) Prognostic factors in medically treated
patients with chronic pulmonary embolism. Chest 119:81–823. https://doi.
org/10.1378/chest.119.3.818
2. Riedel M, Stanek V, Widimsky J, Prerovsky I (1982) Longterm follow-up of
patients with pulmonary thromboembolism. Late prognosis and evolution
of hemodynamic and respiratory data. Chest 81:151–158. https://doi.org/1
0.1378/chest.81.2.151
3. Sanchez O, Helley D, Couchon S et al (2010) Perfusion defects after
pulmonary embolism: risk factors and clinical significance. J Thromb
Haemost 8:1248–1255. https://doi.org/10.1111/j.1538-7836.2010.03844.x
4. Cosmi B, Nijkeuter M, Valentino M, Huisman MV, Barozzi L, Palareti G (2011)
Residual emboli on lung perfusion scan or multidetector computed
tomography after a first episode of acute pulmonary embolism. Intern
Emerg Med 6:521–528. https://doi.org/10.1007/s11739-011-0577-8
5. Ruggiero A, Screaton NJ (2017) Imaging of acute and chronic
thromboembolic disease: state of the art. Clin Radiol 72:375–388. https://doi.
org/10.1016/j.crad.2017.02.011
6. Moser KM, Bloor CM (1993) Pulmonary vascular lesions occurring in patients
with chronic major vessel thromboembolic pulmonary hypertension. Chest
103:685–692. https://doi.org/10.1378/chest.103.3.685
7. Hoeper MM, Mayer E, Simonneau G, Rubin LJ (2006) Chronic
thromboembolic pulmonary hypertension. Circulation 113:2011–2020.
https://doi.org/10.1161/CIRCULATIONAHA.105.602565
8. Konstantinides SV, Meyer G, Becattini C, et al (2019) 2019 ESC guidelines for
the diagnosis and management of acute pulmonary embolism developed
in collaboration with the European Respiratory Society (ERS): the task force
for the diagnosis and management of acute pulmonary embolism of the
European Society of Cardiology (ESC). Eur Heart J 41:543–603. https://doi.
org/10.1093/eurheartj/ehz405
9. Delcroix M, Kerr K, Fedullo P (2016) Chronic thromboembolic pulmonary
hypertension. Epidemiology and risk factors. Ann Am Thorac Soc 13:S201–
S206. https://doi.org/10.1513/AnnalsATS.201509-621AS
10. Pepke-Zaba J, Jansa P, Kim NH, Naeije R, Simonneau G (2013) Chronic
thromboembolic pulmonary hypertension: role of medical therapy. Eur
Respir J 41:985–990. https://doi.org/10.1183/09031936.00201612
11. Auger WR, Kerr KM, Kim NH, Fedullo PF (2012) Evaluation of patients with
chronic thromboembolic pulmonary hypertension for pulmonary
endarterectomy. Pulm Circ 2:155–162. https://doi.org/10.4103/2045-8932.
97594
12. Tunariu N, Gibbs SJR, Win Z, et al (2007) Ventilation–perfusion scintigraphy
is more sensitive than multidetector CTPA in detecting chronic
thromboembolic pulmonary disease as a treatable cause of pulmonary
hypertension. J Nucl Med 48:680–684. https://doi.org/10.2967/jnumed.106.
039438
13. Keogh AM, Mayer E, Benza RL, et al (2009) Interventional and surgical
modalities of treatment in pulmonary hypertension. J Am Coll Cardiol 54:
S67–S77. https://doi.org/10.1016/j.jacc.2009.04.016
14. Coulden R (2006) State-of-the-art imaging techniques in chronic
thromboembolic pulmonary hypertension. Proc Am Thorac Soc 3:577–583.
https://doi.org/10.1513/pats.200605-119LR
15. He J, Fang W, Lv B, et al (2012) Diagnosis of chronic thromboembolic
pulmonary hypertension: comparison of ventilation/perfusion scanning and
multidetector computed tomography pulmonary angiography with
pulmonary angiography. Nucl Med Commun 33:459–463. https://doi.org/1
0.1097/MNM.0b013e32835085d9
16. Leone MB, Giannotta M, Palazzini M, et al (2017) A new CT-score as index of
hemodynamic changes in patients with chronic thromboembolic
pulmonary hypertension. Radiol Med 122:495–504. https://doi.org/10.1007/
s11547-017-0750-x
17. Castañer E, Gallardo X, Ballesteros E, et al (2009) CT diagnosis of chronic
pulmonary thromboembolism. Radiographics 29:31–50. https://doi.org/1
0.1148/rg.291085061
18. Mahammedi A, Oshmyansky A, Hassoun PM, Thiemann DR, Siegelman SS
(2013) Pulmonary artery measurements in pulmonary hypertension: the role
Vainio et al. European Radiology Experimental            (2021) 5:45 Page 11 of 12
of computed tomography. J Thorac Imaging 28:96–103. https://doi.org/10.1
097/RTI.0b013e318271c2eb
19. Devaraj A, Wells AU, Meister MG, Corte TJ, Wort SJ, Hansell DM (2010)
Detection of pulmonary hypertension with multidetector CT and
echocardiography alone and in combination. Radiology 254:609–616.
https://doi.org/10.1148/radiol.09090548
20. Sugiura T, Tanabe N, Matsuura Y, et al (2013) Role of 320-slice CT imaging in
the diagnostic workup of patients with chronic thromboembolic pulmonary
hypertension. Chest 143:1070–1077. https://doi.org/10.1378/chest.12-0407
21. Gopalan D, Blanchard D, Auger WR (2016) Diagnostic evaluation of chronic
thromboembolic pulmonary hypertension. Ann Am Thorac Soc 13:S222–
S239. https://doi.org/10.1513/AnnalsATS.201509-623AS
22. Rogberg AN, Gopalan D, Westerlund E, Lindholm P (2019) Do radiologists
detect chronic thromboembolic disease on computed tomography? Acta
Radiol 60:1576–1583. https://doi.org/10.1177/0284185119836232
23. Fedullo PF, Auger WR, Kerr KM, Rubin LJ (2001) Chronic thromboembolic
pulmonary hypertension. N Engl J Med. 345:1465–1472. https://doi.org/10.1
056/NEJMra010902
24. Pepke-Zaba J, Delcroix M, Lang I, et al (2011) Chronic thromboembolic
pulmonary hypertension (CTEPH): results from an international prospective
registry. Circulation 124:1973–1981. https://doi.org/10.1161/CIRCULATIONA
HA.110.015008
25. Wittenberg R, Peters JF, Sonnemans JJ, Prokop M, Schaefer-Prokop C (2010)
Computer-assisted detection of pulmonary embolism: evaluation of
pulmonary CT angiograms performed in an on-call setting. Eur Radiol 20:
801–806. https://doi.org/10.1007/s00330-009-1628-7
26. Chan H, Hadjiiski L, Zhou C, Sahiner B (2008) Computer-aided diagnosis of
lung cancer and pulmonary embolism in computed tomography-a review.
Acad Radiol 15:535–555. https://doi.org/10.1016/j.acra.2008.01.014
27. Galiè N, Humbert M, Vachiery J et al (2015) 2015 ESC/ERS guidelines for the
diagnosis and treatment of pulmonary hypertension. Eur Respir J 46:903–
975. https://doi.org/10.1183/13993003.01032-2015
28. Taboada D, Pepke-Zaba J, Jenkins DP, et al (2014) Outcome of pulmonary
endarterectomy in symptomatic chronic thromboembolic disease. Eur
Respir J 44:1635–1645. https://doi.org/10.1183/09031936.00050114
29. Marcus DS, Olsen TR, Ramaratnam M, Buckner RL (2007) The extensible
neuroimaging archive toolkit: an informatics platform for managing,
exploring, and sharing neuroimaging data. Neuroinformatics 5:11–34.
https://doi.org/10.1385/ni:5:1:11
30. Fedorov A, Beichel R, Kalpathy-Cramer J, et al (2012) 3D slicer as an image
computing platform for the quantitative imaging network. Magn Reson
Imaging 30:1323–1341. https://doi.org/10.1016/j.mri.2012.05.001
31. Zukić D, Vicory J, McCormick M et al (2016) ND morphological contour
interpolation. In: Insight Journal. http://hdl.handle.net/10380/3563. Accessed
9 Aug 2016
32. Albu A, Beugeling T, Laurendeau D (2008) A morphology-based approach
for interslice interpolation of anatomical slices from volumetric images. IEEE
Trans Biomed Eng 55:2022–2038. https://doi.org/10.1109/TBME.2008.921158
33. Ronneberger O, Fischer P, Brox T (2015) U-Net: Convolutional networks for
biomedical image segmentation. In: Navab N, Hornegger J, Wells WM,
Frangi AF (eds) MICCAI 2015: 18th international conference on medical
image computing and computer-assisted intervention, Munich, October
2015, Lecture notes in computer science, vol 9351. Springer, Cham, pp 234–
241. https://doi.org/10.1007/978-3-319-24574-4_28
34. Abadi M, Barham P, Chen J, Chen Z, Davis A, Dean J (2016) TensorFlow: a
system for large-scale machine learning. In: Proceedings of the 12th USENIX
conference on operating systems design and implementation (OSDI'16),
Savannah, 2–4 November 2016
35. Kingma D, Ba J (2015) Adam: a method for stochastic optimization. In:
Proceedings of the 3rd International Conference on Learning
Representations (ICLR 2015), San Diego, 7–9 May 2015
36. Milletari F, Navab N, Ahmadi S (2016) V-Net: Fully convolutional neural
networks for volumetric medical image segmentation. In: Proceedings of
the 2016 4th international conference on 3D vision (3DV), Stanford, 25–28
October 2016
37. Chicco D, Jurman G (2020) The advantages of the Matthews correlation
coefficient (MCC) over F1 score and accuracy in binary classification
evaluation. BMC Genomics 21:6. https://doi.org/10.1186/s12864-019-6413-7
38. Nemec SF, Bankier AA, Eisenberg RL (2013) Pulmonary hyperlucency in
adults. AJR Am J Roentgenol 200:W101–W115. https://doi.org/10.2214/A
JR.12.8917
39. Huang S, Kothari T, Banerjee I et al (2020) PENet—a scalable deep-learning
model for automated diagnosis of pulmonary embolism using volumetric
CT imaging. NPJ Digit Med 3:61. https://doi.org/10.1038/s41746-020-0266-y
40. Tajbakhsh N, Gotway M, Liang J (2015) Computer-aided pulmonary
embolism detection using a novel vessel-aligned multi-planar image
representation and convolutional neural networks. In: MICCAI 2015: 18th
international conference on medical image computing and computer-
assisted intervention, Munich (October 2015) Lecture notes in computer
science, vol 9350. Springer, Cham, pp 62–69
41. Yang X, Lin Y, Su J, et al (2019) A two-stage convolutional neural network
for pulmonary embolism detection from CTPA images. IEEE Access 7:84849–
84857. https://doi.org/10.1109/ACCESS.2019.2925210
42. Liu W, Liu M, Guo X, et al (2020) Evaluation of acute pulmonary embolism
and clot burden on CTPA with deep learning. Eur Radiol 30:3567–3575.
https://doi.org/10.1007/s00330-020-06699-8
43. Öman O, Mäkelä T, Salli E, Savolainen S, Kangasniemi M (2019) 3D
convolutional neural networks applied to CT angiography in the detection
of acute ischemic stroke. Eur Radiol Exp 3:8. https://doi.org/10.1186/s41747-
019-0085-6
44. Hansell DM (2010) Thin-section CT of the lungs: the hinterland of normal.
Radiology 256:695–711. https://doi.org/10.1148/radiol.10092307
45. Goerne H, Batra K, Rajiah P (2018) Imaging of pulmonary hypertension: an
update. Cardiovasc Diagn Ther 8:279–296. https://doi.org/10.21037/cdt.2018.
01.10
46. Arakawa H, Stern EJ, Nakamoto T, Fujioka M, Kaneko N, Harasawa H (2003)
Chronic pulmonary thromboembolism. Air trapping on computed
tomography and correlation with pulmonary function tests. J Comput Assist
Tomogr 27:735–742. https://doi.org/10.1097/00004728-200309000-00010
47. Bartalena T, Oboldi D, Guidalotti PL, et al (2008) Lung perfusion in patients
with pulmonary hypertension: comparison between MDCT pulmonary
angiography with minIP reconstructions and 99mTc-MAA perfusion scan.
Invest Radiol 43:368–373. https://doi.org/10.1097/RLI.0b013e31816901e2
48. Sherrick AD, Swensen SJ, Hartman TE (1997) Mosaic pattern of lung
attenuation on CT scans: frequency among patients with pulmonary artery
hypertension of different causes. AJR Am J Roentgenol 169:79–82. https://
doi.org/10.2214/ajr.169.1.9207504
49. Kligerman SJ, Henry T, Lin CT, Franks TJ, Galvin JR (2015) Mosaic attenuation:
etiology, methods of differentiation, and pitfalls. Radiographics 35:1360–
1380. https://doi.org/10.1148/rg.2015140308
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Vainio et al. European Radiology Experimental            (2021) 5:45 Page 12 of 12
